Accueil
Tamer Önder
Tamer Önder
Affiliations
School of Medicine, Koç University, Istanbul, 34450, Turkey.
ORCID: http://orcid.org/0000-0002-2372-9158
Publications (8)
Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer.
Oncogene
Avec:
Hilal Saraç
,
Tunç Morova
,
Elisabete Pires
,
James McCullagh
,
Anıl Kaplan
,
Ahmet Cingöz
,
Tugba Bagci-Onder
,
Tamer Önder
,
Akane Kawamura
,
Nathan A Lack
Effect of HER2-low status on brain metastasis-free survival and survival after brain metastasis in patients with breast cancer.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Avec:
Tuğba Önder
,
Cengiz Karaçin
Relationship between HER2-low status and efficacy of CDK4/6 inhibitors in advanced breast cancer: a real-world study.
International journal of clinical oncology
Avec:
T Önder
,
Ö Ateş
,
I Öner
,
C Karaçin
Trastuzumab-induced optic neuritis: "blindness" side effect.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Avec:
Tuğba Önder
,
Cengiz Karaçin
Development, characterization, and hematopoietic differentiation of Griscelli syndrome type 2 induced pluripotent stem cells.
Stem cell research & therapy
Avec:
Gülen Güney-Esken
,
Özgür Doğuş Erol
,
Burcu Pervin
,
Gülben Gürhan Sevinç
,
Tamer Önder
,
Elif Bilgiç
,
Petek Korkusuz
,
Ayşen Günel-Özcan
,
Duygu Uçkan-Çetinkaya
,
Fatima Aerts-Kaya
Hydatid Cyst of the Spine: A Rare Case Report
Turkiye parazitolojii dergisi
Avec:
Sevil Alkan Çeviker
,
Cihan Yüksel
,
Alper Şener
,
Taylan Önder
,
Mehmet Hüseyin Metineren
,
Çisil Özel
,
Ömer Serdar Akgül
Predicting survival after brain metastases in patients with bladder cancer.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Avec:
T Önder
,
C Karaçin
,
E Kekilli
,
F Göksel
,
E Sertesen
,
I Deliktaş Onur
,
Ö Ateş
,
F Yıldız
,
Ü Y Arslan
Triglyceride-Glucose Index: A Candidate Prognostic Marker in HR-Positive/HER2-Negative Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors.
Clinical breast cancer
Avec:
Tuğba Önder
,
Öztürk Ateş
,
İrem Öner
,
Cengiz Karaçin
Réseau de co-auteurs
Tuğba Önder
3 collaborations
Cengiz Karaçin
3 collaborations
T Önder
2 collaborations
Ö Ateş
2 collaborations
C Karaçin
2 collaborations
Hilal Saraç
1 collaboration
Tunç Morova
1 collaboration
Elisabete Pires
1 collaboration
James McCullagh
1 collaboration
Anıl Kaplan
1 collaboration
Ahmet Cingöz
1 collaboration
Tugba Bagci-Onder
1 collaboration
Akane Kawamura
1 collaboration
Nathan A Lack
1 collaboration
I Öner
1 collaboration
Gülen Güney-Esken
1 collaboration
Özgür Doğuş Erol
1 collaboration
Burcu Pervin
1 collaboration
Gülben Gürhan Sevinç
1 collaboration
Elif Bilgiç
1 collaboration
Petek Korkusuz
1 collaboration
Ayşen Günel-Özcan
1 collaboration
Duygu Uçkan-Çetinkaya
1 collaboration
Fatima Aerts-Kaya
1 collaboration
Sevil Alkan Çeviker
1 collaboration
Cihan Yüksel
1 collaboration
Alper Şener
1 collaboration
Taylan Önder
1 collaboration
Mehmet Hüseyin Metineren
1 collaboration
Çisil Özel
1 collaboration
Ömer Serdar Akgül
1 collaboration
E Kekilli
1 collaboration
F Göksel
1 collaboration
E Sertesen
1 collaboration
I Deliktaş Onur
1 collaboration
F Yıldız
1 collaboration
Ü Y Arslan
1 collaboration
Öztürk Ateş
1 collaboration
İrem Öner
1 collaboration